Kissei Pharmaceutical Co., Ltd. (KSPHF)
Market Closed
10 Jun, 20:00
OTC PINK 
JPX Primary OTC PINK $
25. 77
0
0%
$
1.07B Market Cap
- P/E Ratio
1.26% Div Yield
100 Volume
- Eps
$ 25.77
Previous Close Want to track KSPHF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
KSPHF closed yesterday higher at $25.77, an increase of 0% from Tuesday's close, completing a monthly increase of 0% or $0. Over the past 12 months, KSPHF stock lost -14.8943%.
KSPHF pays dividends to its shareholders, with the most recent payment made on Jun 01, 2026. The next estimated payment will be in 1 weeks ago on Jun 01, 2026 for a total of $0.4182.
The last earnings report, released on May 07, 2026, missed the consensus estimates by -33.96%. On average, the company has fell short of earnings expectations by -36.6834%, based on the last three reports.
Kissei Pharmaceutical Co., Ltd. has completed 5 stock splits, with the recent split occurring on Mar 26, 1996.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on JPX (JPY).
Kissei Pharmaceutical Co., Ltd. (KSPHF) FAQ
What is the stock price today?
The current price is $25.77.
On which exchange is it traded?
Kissei Pharmaceutical Co., Ltd. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is KSPHF.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 1.26%.
What is its market cap?
As of today, the market cap is 1.07B.
Has Kissei Pharmaceutical Co., Ltd. ever had a stock split?
Kissei Pharmaceutical Co., Ltd. had 5 splits and the recent split was on Mar 26, 1996.
Kissei Pharmaceutical Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mutsuo Kanzawa CEO | OTC PINK Exchange | JP3240600001 ISIN |
| JP Country | 1,779 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Kissei Pharmaceutical Co., Ltd., based in Matsumoto, Japan, is a reputable entity in the pharmaceutical industry, focusing primarily on the Japanese market. Since its establishment in 1946, originally known as Kissei Yakuhin Kogyo Co., Ltd., the company has made significant strides in research, development, manufacturing, and sales of pharmaceuticals. Renamed in October 1964, Kissei Pharmaceutical has expanded its reach and diversification into various related sectors, including system development, information processing, construction contracting, and even food manufacturing, showcasing its versatility and commitment to innovation in healthcare and related services.
Products and Services
Kissei Pharmaceutical offers a wide range of pharmaceutical products and services, detailed as follows:
- Kalogra tablets: Prescribed for the treatment of ulcerative colitis, addressing inflammation and ulcers in the innermost lining of the large intestine and rectum.
- Tabuneos capsules: Developed for patients suffering from microscopic polyangiitis and granulomatous polyangiitis, offering hope in managing these rare, autoimmune diseases.
- Minirin Melt OD tablets, Malizeb tablets, Tavaris tablets, and Beova tablets: Catering to a variety of conditions from chronic idiopathic thrombocytopenic purpura, demonstrating the company's broad focus on developing solutions for complex health issues.
- Darbepoetin Alfa BS injection JCR: An innovative solution for the treatment of renal anemia, underscoring Kissei’s commitment to addressing chronic conditions.
- Product Pipeline: With drugs like CG0070 for bladder cancer, Linzagolix for uterine fibroids and endometriosis, and various other drugs in different stages of clinical trials, Kissei Pharmaceutical is actively working on pioneering treatments for the future.
- Additional Ventures: Beyond pharmaceuticals, Kissei engages in a wide array of other businesses, including food products specially designed for medical needs, equipment rentals, insurance, and even noodle manufacturing. The company also invests in construction of facilities and development of computer systems and cloud services, highlighting its diverse business interests aligned with healthcare and technological innovation.
Contact Information
Address: 19-48, Yoshino
Phone: 81 263 25 9081
Website: https://www.kissei.co.jp
